Collaboration to focus on new plant lines and other plant-based technologies aimed at efficient production scale-up of KBio’s current and future pipeline
LONDON — September 28, 2022— KBio, a leading developer of new biological treatments derived from a plant-based production system, today announced the formation of a strategic collaboration with Leaf Expression Systems Ltd. (LES), the leading UK-based plant-made pharmaceuticals R&D company. Through this collaboration, KBio will explore how LES’ cutting-edge technologies can be applied to its existing plant-based platform to enhance…
ValiRx, a life science company focused on early-stage cancer therapeutics and women's health, has bolstered its drug discovery and therapeutic expertise with the appointment of Dr Cathy Tralau-Stewart as its Interim Chief Scientific Officer (CSO).
With more than 20 years’ senior academic and industry leadership experience, Cathy joins ValiRx from drug discovery company C4X Discovery, where she was CSO and managed the project portfolio and research and development (R&D) strategy. Prior to this, she was Senior Director of Alliances for Takeda Pharmaceuticals where she was responsible…
Cambridge Network celebrates a milestone birthday as it turns 25, a testament to its success as an effective and established networking organisation, operating at the heart of the Cambridge cluster.
The concept of a formalised Cambridge business networking community was a new idea when the Network was set up back in 1997 by an influential group comprising of the then Vice-Chancellor of the University, now Lord Broers, with entrepreneurs Hermann Hauser, David Cleevely, Nigel Brown, Fred Hallsworth and Anthony Ross.
It began as a simple idea, of bringing together businesses and academia. Fast…
Your monthly round up of employee engagement activities, read more
Click here to view the August edition of The Meeting Place
This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has acquired Fidelis Research, an 85-site clinical biospecimen collection network in Southeastern Europe with headquarters in Sofia, Bulgaria. Fidelis Research also possesses cell isolation capabilities and provides custom…
AMSBIO announce RNAdvantage – the first product in a new range of stabilization solutions that provide robust protection for your RNA samples at ambient temperature. Designed to protect and preserve RNA from most tissues, cultured cells, bacteria, and yeast for up to 14-days, RNAdvantage eliminates the traditional costs of flash freezing samples dry-ice shipping and freezer storage.
From the point at which your tissue samples are collected, RNAdvantage permeates the tissue to stabilize the RNA at room temperature. Samples can also be protected upon purification with no extra clean-…
Leading global drug development consultancy Boyds has added to its team with the appointment of experienced regulatory affairs professional Katherine Bowen in response to a rise in demand for its specialist regulatory services.
With more than 14 years’ experience in regulatory affairs across both mid to large pharma and consultancies, Katherine joins Boyds as Senior Director of Regulatory Affairs.
Katherine joins Boyds from regulatory consultancy DLRC where she was Head of Regulatory Teams and Principal Consultant leading a team of regulatory consultants as well as providing strategic and…
• Stevenage Bioscience Catalyst is leading the way by introducing the Warp It recycling scheme
• The online reuse platform will enable occupier companies to donate and receive lab and office equipment, supplies and furniture
• This will reduce costs and carbon footprints for occupiers
Stevenage Bioscience Catalyst (SBC) is the first science park in the UK to sign up to the Warp It reuse platform. The platform enables companies to donate or receive surplus lab and office equipment, supplies and furniture.
Dr Sally Ann Forsyth OBE, CEO at SBC, said, “Stevenage Bioscience Catalyst is home to…
VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the launch of its Good Manufacturing Practice (GMP-) grade VivoSTART™ leukopaks. Leukopaks contain concentrated white blood cells and are used to research and manufacture cell and gene therapies.
“This GMP-grade leukopak product introduction underscores BioIVT’s commitment to being a high quality, global immune cell provider,” said…